ISSN: 1473-7175

Journal Home

Journal Guideline

Expert Review of Neurotherapeutics Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Neurotherapeutics is a journal indexed in SJR in Neuroscience (miscellaneous) and Neurology (clinical) with an H index of 103. It has a price of 2395 €. It has an SJR impact factor of 1,162 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,162.

Expert Review of Neurotherapeutics focuses its scope in these topics and keywords: treatment, antipsychotics, astrocytes, avenue, benzodiazepines, challenges, children, chronic, compulsive, demyelinating, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neurology (clinical) (Q1) Pharmacology (medical) (Q1) Neuroscience (miscellaneous) (Q2)

Price

2395 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,162

SJR Impact factor

103

H Index

107

Total Docs (Last Year)

309

Total Docs (3 years)

9276

Total Refs

1112

Total Cites (3 years)

281

Citable Docs (3 years)

3.3

Cites/Doc (2 years)

86.69

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Neuroscience Q1
Annual Review of Neuroscience Q1
Neuron Q1
EMBO Journal Q1
Trends in Neurosciences Q1

Compare this journals

Aims and Scope

Best articles by citations

MRI for identification of progression in brain tumors: from morphology to function

Management of Guillain-Barre syndrome

Increased patient autonomy through long-term antipsychotic delivery systems for the treatment of schizophrenia

Charting a path toward combination therapy for Alzheimer's disease

Chronic migraine and medication overuse: still a debate

Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target

Update on therapies for cluster headache

Behavioral treatment of insomnia

Schizophrenia: a personal testament

Estrogen therapy in postmenopausal women with Parkinson's disease

Treatment of epilepsies associated with typical absences

Neurocysticercosis: the good, the bad, and the missing

SHOW MORE ARTICLES

Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management

New developments in pharmacotherapy of pediatric anxiety disorders

Mental and Behavioral Dysfunction in Movement Disorders: An International Symposium

Current and future therapeutic strategies for Alzheimer's disease and related dementias

Will neurogenomics revolutionize neurotherapeutics?

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence

Role of progesterone and other neuroactive steroids in anxiety disorders

Alzheimer's disease from researcher to caregiver: a personal journey and call to action

Virtual reality: a new tool for panic disorder therapy

Advances in revascularization for acute ischemic stroke treatment

Use of botulinum toxin type A in poststroke spasticity

Challenging views of Alzheimer's disease